EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER

The Lancet

Volumn 333, Issue 8631, 1989, Pages 182-185

  Nicholson, Stewart ^a   Halcrow, P ^a   Farndon, JohnR ^a   Sainsbury, J R C ^a   Chambers, P ^a   Harris, AdrianL ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; HYDROCORTISONE; RADIOISOTOPE; TAMOXIFEN;

BREAST CANCER; CANCER RECURRENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR BINDING;

ADULT; AGED; AMINOGLUTETHIMIDE; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMAN; HYDROCORTISONE; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; SUPPORT, NON-U.S. GOV'T; TAMOXIFEN;

EID: 0024531977     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(89)91202-6     Document Type: Article

References (43)

1. Three fatal cases of probable allergy to human milk
2. Observation d'intolérance isolée au soja a forme de chocs anaphylactiques chez un nourisson
3. Kunitz soybean tripsin inhibitors. A specific allergen in food anaphylaxis
4. Sesam und soja Seltene allergene?
5. Soybean as a possible important source of allergy
6. Hypersensitivity to soybeans
7. Les accidents allergiques respiratoires dus aux olèagineux
8. Bronchial asthma due to soybean allergy: report of a case with audiovisual documentation
9. Immediate and late onset of asthma from occupational exposure to soybean dust
10. Asthma sévère par inhalation de poussière de soja
11. Bronchial asthma of occupational origin. A review
12. Allergens that cause asthma. Identification and quantification
13. Occupational allergic lung diseases caused by organic agents
14. Endemic asthma due to castor bean dust
15. An outbreak of bronchial asthma in South Africa affecting more than 200 persons caused by castor bean dust from an oil-processing factory
16. Collective asthma, simulating an epidemic provoked by castor-bean dust
17. Asthma outbreak during a thunderstorm
18. Weather or not
19. The decline of New Orleans asthma epidemic
20. Epidermal growth factor
21. A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles
22. Close similarity of epidermal growth factor receptor and v-erb B oncogene protein sequences
23. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines
24. Characterization of estrogen responsive transforming activity in human breast cancer cell lines
25. Transforming growth factors produced by certain human tumour cells polypeptides that interact with epidermal growth factor receptors
26. Autocrine and paracrine growth regulation of human breast cancer
27. Epidermal growth factor binding by breast tumour biopsies and relationship to oestrogen receptor and progestin receptor levels
28. Epidermal growth factor receptors in human breast cancer
29. Epidermal growth factor receptors and oestrogen receptors in human breast cancer
30. Receptors for epidermal growth factor in human mammary carcinomas and their metastases
31. Quantitative assays of epidermal growth factor receptor m human breast cancer: cut-off points of clinical relevance
32. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer
33. Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer
34. New storage procedure for human tumour biopsies prior to oestrogen receptor measurement
35. Assessment of response to therapy in advanced breast cancer
36. Antihormone treatment of stage IV breast cancer
37. Aminoglutethimide for the treatment of advanced postmenopausal breast cancer
38. Treatment of primary breast cancer in the elderly with "Nolvadex" alone
39. Systemic therapy—Prolonged survival or growth control?
40. Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer
41. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples
42. Oestrogen receptors and the response to endocrine therapy in advanced breast cancer
43. Response to tamoxifen in estrogen receptor-poor metastatic breast cancer